Journal of
Medicinal Plants Research

  • Abbreviation: J. Med. Plants Res.
  • Language: English
  • ISSN: 1996-0875
  • DOI: 10.5897/JMPR
  • Start Year: 2007
  • Published Articles: 3840

Full Length Research Paper

Effect of Combretum molle (Combretaceae) seed extract on hematological and biochemical parameters

Merkin Anato
  • Merkin Anato
  • Department of Biology, College of Natural Sciences, Jimma University, Jimma, Ethiopia.
  • Search for this author on:
  • Google Scholar
Mesele Bezabih
  • Mesele Bezabih
  • Institute of Health Science, Jimma University, Jimma, Ethiopia.
  • Search for this author on:
  • Google Scholar
Tsige Ketema
  • Tsige Ketema
  • Department of Biology, College of Natural Sciences, Jimma University, Jimma, Ethiopia.
  • Search for this author on:
  • Google Scholar


  •  Received: 17 October 2017
  •  Accepted: 29 November 2017
  •  Published: 03 February 2018

 ABSTRACT

Combretum molle (Combretaceae) is widely used traditional medicinal plant for treatment of different illnesses in most parts of Africa. However, its in vivo toxic effect is not evaluated yet. Thus, the aim of this study was to evaluate cytotoxic effect of C. molle seed extract on biochemical and hematological parameters using mice. Accordingly, effect of seed extract of the plant on hematological and biochemical parameters and on tissues of different organs were determined. Blood sample collected on the next day of the last dose administration was used for further analysis. Organs were collected in formalin for histological study. Result of the study showed that seed extract of C. molle did not cause significant effects on most red blood cells (RBCs) indices. Also, except eosinophil count, all white blood cells (WBCs) indices showed significant reduction (P<0.05) under use of almost all doses of the seed extract. Level of liver enzymes such as glutamic oxaloacetate transaminase (sGOT) and glutamic pyruvic transaminase (sGPT) showed significant increment (P<0.05) in mice treated with different doses of the plant seed extract, while concentration of albumin was significantly reduced (P<0.05). Similarly, significant increament (P<0.05) in levels of kidney function indicators urea and creatinine was observed. At relatively lower dose (125 mg/kg), the crude extract of C. molle seed showed lower effects on haematological, biochemical and immunological parameters. As dose increased, its cytotoxic effect increased.
 
Key words: Combretum molle, hematological, biochemical, histopathology.


 INTRODUCTION

Combretum molle is one of the herbal plants belonging to the family Combretaceae which includes 20 genera and about 600 species (Miaffo et al., 2015). This plant is popularly used in South Africa for the treatment of stomach pains, dysentery, gastric ulcers, abdominal disorders, and other illnesses (Eloff et al., 2008). Also, roots of C. molle seem to have a variety of uses against hookworm, stomach pains, snake bite, leprosy, fever, dysentery, general body swellings, and abortion as well as for swelling of the abdomen, sterility and constipation (Fyhrquist et al., 2012). This plant bark and root in vitro tested in different African countries for treatment of bacteria (Sahlu, 2013; Regassa and Araya, 2012). Also, seed of the plant tested against fungi and bacteria (Masoko et al., 2007; Amare and Tadesse, 2016), and leaf against helminths (Ademola and Eloff, 2010). In addition, C. molle bark extract was tested for its in vitro antimicrobial activities (Regassa and Araya, 2012; Amare and Tadesse, 2016).
 
Moreover, different species of Combretum have been reported to have in vitro anti-plasmodial activity against chloroquine sensitive Plasmodium falciparum strains (Benoit et al., 1996; Ancolio et al., 2002; Karou et al., 2003; Sanon et al., 2013). Furthermore, tannin, stem bark, seed and leave extract of C. molle plant have revealed in vitro activity against P. falciparum (Asres and Balcha, 1998; Asres et al., 2001; Gansane et al., 2010). Almost every part of these plants (roots, leaves, seeds, twigs, and stem bark) has been used in African traditional medicine for the treatment of various ailments and diseases (Miaffo et al., 2015). Similarly, seed of this plant is widely used by traditional medicinal plants practitioners in Ethiopia, mainly among rural residents of Gambella region, for treatment of malaria, HIV and other diseases. While seed of C. molle plant widely used by local people for treatment of various illness; its effects on haemato-logical and biochemical parameters were not evaluated yet. Therefore, the objective of the current study was to investigate in vivo effect of seed extract of the C. molle plant on haematological and biochemical parameters in mice.


 MATERIALS AND METHODS

Plant material preparation
 
The seed of C. molle was collected from the vicinities of Gambella region, Agnua zone, Gog woreda (about 886 km south west of Addis Ababa). The voucher specimen [CM7 (C. molle No.7)] was identified by Mr. Zewdie Achiso and deposited at Jimma University Herbarium (JUH), Department of Biology, Jimma University, Ethiopia. Seed of the plant part was collected and dried in the processing room and then powdered, kept at room temperature in a well-closed and amber bottle until extracted. The dried and powdered seed (100 g) was extracted by maceration in 300 mL of 80% methanol for three consecutive days (72 h) at room temperature. The extraction process was facilitated by using frequent shaking. The mixture was first filtered using cotton wool and then with Whatman filters paper No. 1 (Whatman®, England). The residue was re-macerated for another 72 h twice and filter. The combined filtrate was then dried by rotary evaporator (Buchi Rota Vapor, Switzerland) at a temperature of 40°C and 45 rpm. After dried in water bath, a total dry extract was harvested and the dried extract kept at -20°C in a tightly closed bottle in a refrigerator until used for testing.
 
Experimental animals
 
A total of 65 Swiss albino mice were used for acute toxicity and cytotoxic activity testing of C. molle seed extract. Accordingly, both sex mice, age 8 to 10 weeks, and weighed of 30 to 40 g were maintained at temperature of 22±3°C, relative humidity of 40 to 50% and 12 h light/12 h dark cycle. The animals were housed in transparent plastic cage with SS sipper 250 mL water bottle. Wood shaving was used as bedding and it was replaced every morning after the cage was cleaned and disinfected with 70% alcohol. The animals were kept under unlimited access to food and water. The mice were allowed to acclimatizing to the laboratory environment for at least one week before being subjected to the experiments.
 
Acute toxicity determination
 
Mice were randomly arranged into four groups (each group containing 5 non-infected) for acute toxicity testing of the crude extract of C. molle seed at different dose levels (500, 1000, and 2000 mg/kg), and the last group, considered as control (Ketema et al., 2015). The acute toxicity was carried out in accordance to OECD guidelines. The mice were acclimatized and then fast for about 3 h. The extract was administered to the animals orally after it dissolved in 20% of Tween 80 in saline. The control group received 0.5 mL of 20% of Tween 80 in saline through the same route. Any acute sign of toxicity and mortality of each group within 24 h after administration of the extract was recorded. Toxicity signs such as death, changes in physical appearance, and behaviour including loss of appetite, hair erection, lacrimation, tremors, convulsions, salivation, and diarrhoea, and other signs of overt toxicity were directly observed for 72 h. The feeding condition (consumption of pellet and water) was recorded for 14 days.
 
Animal treatment and study protocol
 
Animals were randomized into four groups (I-IV) each containing four mice grouped for haematological and biochemical study. Doses of the extract used for this assay was 100 mg/kg (group I), 250 mg/kg (group II) and 500 mg/kg (group III) and 0.5 mL 20% of Tween 80 in saline (group IV or negative control). Animals were sacrificed 24 h after the last doses were administered (orally) lasted seven days. The mice at the time of sacrifice were weighed and then terminally anaesthetized. Blood sample was collected through cardiac puncture and collected in EDTA coated tubes. The abdominal cavity was opened through a midline abdominal incision and the liver and kidney were immediately removed and placed in fixative and processed for histological study.
 
Haematological and biochemical assay
 
About 0.2 mL blood sample collected in EDTA tube was used for quantification of total WBC, lymphocytes, monocytes, basophils eosinophil, neutrophils, RBCs, Haemoglobin (Hb), Haematocrit (HCT), platelets, mean corpuscular volume (MCV), mean corpuscular haemoglobin concentration (MCHC) and mean corpuscular haemoglobin (MCH) using CBC machine. About 1 mL of the remaining blood sample was centrifuged at 10,000 rpm for 10 min. The supernatant (plasma) was transferred into new Eppendorf tube and followed by measurement of liver enzymes, serum glutamic oxaloacetate transaminase (sGOT), serum glutamic pyruvic transaminase (sGPT), and albumin (Alb); indicators of kidney function such as creatinine (Cr) and urea; inflammation test, C-reactive protein (CRP) using LAMBDA 750 UV/Vis/NIR Spectrophotometer.
 
Histological study
 
For histological analysis, liver and kidney of the sacrificed mice were collected in 10% buffered neutral formaldehyde; paraffin-embedded liver and kidney tissues were labelled and stained with hematoxylin and eosin. Slides were coded and scored for histological evidence of liver and kidney damages.
 
Data analysis
 
All data was analysed using SPSS software (version 20.0) and the results were expressed as mean ± standard error of mean (SEM). One-way analysis of variance (ANOVA) was used to compare results among and within groups for differences followed by Turkey’s HSD post-hoc test. Sample analysis was repeated at least three times to get solid statistical data. Significance level was considered at P<0.05.
 
Ethical consideration
 
The study was ethically approved by the Ethical Review Committee of the College of Natural Sciences of Jimma University, Ethiopia. Mice were handled in humane way and extreme precautions were taken to avoid stress induced by poor handling techniques. Blood samples were collected from mice under final anaesthesia. 


 RESULTS

Acute toxicity
 
Physical characteristics such as body weight change, sign of any toxicity, regular measurement of water and food consumed, and any behavioral changes among the mice were assessed every day. Accordingly, significant body weight differences between treated and control groups over the observed period was not observed. Also, adverse effects that require modification of the procedure were not encountered. Likewise, differences were not seen in amount of pellet and volume of water consumed between treated and control groups.
 
Haematological parameters test
 
Outcomes of hematological parameter showed that, use of higher doses of crude extract C. molle seed for seven days cause significant (P<0.05) reduction of count of RBCs, Hb and HCT levels compared to the control group. On the other hand, relatively lower doses of the seed extract (100 and 250 mg/kg) caused significantly (P<0.05) increased count of platelet. However, as the dose increased to 500 mg/kg, platelet count reduced, but not significantly different from the control group. Other hematological parameters such as MCV, MCH, MCHC and RDW-CV were not affected in mice that received the treatment (Table 1).
 
 
Biochemical tests
 
 
The two kidney function indicators; urea and creatinine were significantly affected under use of higher doses of the seed extract (250 and 500 mg/kg) (Figure 1). Likewise, level of liver enzymes were affected in mice recived relatively high dose of the seed extract. At highest dose (500 mg/kg), level of GPT enzyme was significantly (P<0.05) elevated.While level of the other enzyme, GOT, was significantly increased in mice treated with alldoses of the extract (100, 250, and 500 mg/kg) (Figure 2). On the other hand, level of albumin showed significant reduction in mice treated with the two higher doses (250 and 500 mg/kg) (Figure 3).  On the other hand, the plant caused substantial production of one of the inflammation reaction indicators. Under all doses (100, 250 and 500 mg/kg), level of C-reactive protein showed significant (P<0.05) increment (Figure 4).

 

 

Effect of C. molle seed extract on immune cells
 
Effect of the plant seed extract on innate immune cells such as basophils showed variability. Under lowest dose (100 mg/kg), percentage of basophils showed significant increment (P<0.05), while as dose increased to 250 and then 500 mg/kg, the level of this immune cell significantly decrease (P<0.05) as compared to the control mice. On the other hand, eosinophils count showed consistent significant increment (P<0.05) at relatively high doses (250 and 500 mg/kg). Except, at the lowest dose (100 mg/kg) for lymphocytes count, under all doses, differences were not observed between the control and treated groups. Moreover, almost all immune cells showed significant (P<0.05) reduction under use of the highest dose (500 mg/kg) of the extract (Figure 5).
 
 
 
Histological analysis
 
 
Higher dose of seed extract of C. molle (500 mg/kg) caused necrosis of cells of kidney and liver (Figure 6). While, at relatively the lowest doses use (100 and 250 mg/kg), kidney cells were normal, but liver cells showed slight changes such as fatty and water charges.
 

 


 DISCUSSION

Despite wide use of C. molle as medicinal plant for treatment of various ailment including helminthic, protozoal, bacterial and other infectious diseases in different parts of Africa (McGaw et al., 2001; Fyrquist et al., 2002; Bussmann et al., 2006; Grønhaug et al., 2008), studies conducted on its in vivo toxicity test is scanty. According to the traditional practice of the local community, the seed of the plant is used after it is extracted by water as a solvent. Thus, the current study methanol was used as a better solvent for the extraction. Also to mimic human practice in local community, after single oral dose acute toxicity testing, seed crude extract of the plant was administered for seven consecutive days. Accordingly, the crude extract of C. molle seed showed less acute toxicity even at highest dose (2000 mg/kg). However, its longer use (seven days) even at low doses (100 mg/kg) had negative impact on proper functioning of kidney and liver. This was observed by excess secretion of liver enzymes (GPT and GOT), and reduction in production of protein (albumin) by liver cells. It is believed that a rise in plasma enzymes (GPT and GOT) levels are the pertinent indicators for liver toxicity (hepatoxicity) (Singh et al., 2011).
 
The estimation of this enzyme is a more specific test for detecting any liver abnormalities since it is primarily created in the liver (Amacher, 2002). Albumin is the main protein in blood and is made by the liver. Hepatotoxicity leads to decrease in albumin production (Thapa and Walia, 2007). So, that significant reduction in level of albumin is direct indication for failure of liver to produce adequate level of this protein. Likewise, excess levels of creatinine and urea in plas-ma of mice treated with the plant extract was detected. Usually, kidneys maintain optimum chemical composition of the body fluids by acidification of urine and removal of metabolite wastes as creatinine, urea, uric acid, and ions (Biyani et al., 2003). Thus, the observed excess secretion of urea and creatinine has implication on the toxic potential of the seed extract on kidney. This revealed that a continuous use of the plant seed extract has toxic effects on vital organs. This was more evidenced by histological study of tissues of different organs, where at the highest dose (500 mg/kg) cause intense necrosis of cells of the organs (liver and kidney). The seed extract of C. molle caused excess secretion of CRP, an inflammation indicator in mice treated with even at low doses.
 
This protein is a special type of protein (plasma protein) produced by the liver cells only during episodes of acute inflammation, in response to pro-inflammatory cytokines (Zhang and Jianxiong, 2007). As a result, level of CRP, as indicator of systemic inflammation, in plasma highly increases during acute phase response to tissue injury, infection, or other inflammatory stimuli (Gruys et al., 2005). Different in vitro studies suggested that mollic acid glucoside isolated from C. molle leaves has anti-inflammatory and anti-asthmatic activities (Ojewole et al., 2008; Shah et al., 2011; Yeo et al., 2012). However, in the current in vivo study, the observed elevated level of CRP, an indicator of systemic inflammation, could be due to the damaged liver, since elevated liver enzymes are associated with higher CRP concentrations and liver is the main produced of CRP (Kerner et al., 2005). Population of Gambella region, Ethiopia (where the plant is collected) has a practice of using this plant for some days (seven days are common) continuously for treatment of different aliments (personal observation). This practice might prone the users for unexpected inflammation reaction even at low doses and increases vulnerability to various diseases, such as rheumatoid arthritis, atherosclerosis and asthma (Mueller et al., 2010).
 
Some hematological parameters such as RBC count, Hb and HCT levels were significantly reduced in mice treated with the highest dose of the plant seed extract. It shows that at high dose use, seed extract of the C. molle plant could also have toxic effect on RBC indices and increase susceptibility to anemic condition. On the other hand, low doses of the plant seed extract associated with excess production of platelets count. The observed elevated count of platelet in mice treated with 250 mg/kg dose might be related to the organs damage. It appears that platelet homeostasis is controlled by thrombopoietin, a glycoprotein hormone produced by the liver and kidney which regulates the production of platelets. Damaged liver and kidney might increase release of this hormone to the blood and increases production of platelets. This was evidenced by
the renal or liver failure conditions associated with the increased platelet production in patients with kidney and liver problems (Linthorst et al., 2002; Makar et al., 2013). This is because of high level of thrombopoietin in blood of patients which causes abnormal production of platelets (Makar et al., 2013).

 


 CONCLUSION

At relatively lower dose, C. molle seed extract did not cause effects on haematological and biochemical para-meters. Thus, further isolation and evaluation of active components of the seed extracts for their toxicity and testing against pathogens should be a priority area of investigation.

 


 CONFLICT OF INTERESTS

The authors have not declared any conflict of interests.



 REFERENCES

Ademola O, Eloff N (2010). In vitro anthelmintic activity of Combretum molle ex (Combretaceae) against Haemonchus contortusova and larvae. Vet. Parasitol. 169:198-203.
Crossref
 

Amacher DE (2002). A toxicologist's guide to biomarkers of hepatic response. Hum. Exp. Toxicol. 21:253-262.
Crossref

  
 

Amare T, Tadesse E (2016). In vitro Antibacterial Effect of Combretum molle and Fr1 against Staphylococcus aureus and E. coli Isolated from Bovine Mastitis. World J. Biol. Med. Sci. 3(1):115-131.

  
 

Ancolio C, Azas N, Mahiou V, Ollivier E, di Giorgio C, Keita A, Timon-David P, Balansard G (2002). Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome. Phytother. Res. 16:466-469.
Crossref

  
 

Asres K, Bucar F, Knauder E, Yardley V, Kendrick H, Croft SL (2001). In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle. Phytother. Res. 15(7):613-617.
Crossref

  
 

Asres K, Balcha F (1998). Phytochemical screening and in vitro antimalarial activity of the stem bark of Combretum molle R. Br ex G Don. Ethiop. Pharm. J. 16:25-33.

  
 

Benoit F, Valentin A, Pelissier, Y, Diafouka F, Marion C, Kone-Bamba D, Kone M, Mallie M, Yapo A, Bastide JM (1996). In vitro antimalarial activity of vegetal extracts used in west African traditional medicine. Am. J. Trop. Med. Hyg. 54:67-71.
Crossref

  
 

Biyani MK, Banavalikar MM, Suthar AC, Shahani S, Sivakami, S, Vidri J (2003). Antihyperglycemic Effects of Three extracts from Momordica charantia. J. Ethnopharmacol. 88:107-111.
Crossref

  
 

Bussmann RW, Gilbreath GG, Soilo J (2006). Plant Use of the Massai of Sekenani Valley, Massai Mara, Kenya. J. Ethnobiol. Ethnomed. 4:24.

  
 

Eloff JN, Katerere DR, Mcgaw LJ (2008). The biological activity and chemistry of the southern African Combretaceae. J. Ethnopharmacol. 119:686-699.
Crossref

  
 

Fyhrquist P, Mwasumbi L, Haeggstro CA, Vuorela H, Hiltunen R, Vuorela P (2012). Ethnobotanical and antimicrobial investigation on some species of Terminalia and Combretum (Combretaceae) growing in Tanzania. J. Ethnopharmacol. 79:169-177.
Crossref

  
 

Fyrquist P, Mwasumbi L, Haeggstrőm CA, Vuorela H, Hiltunen R, Vuorela P (2002). Ethnobotanical and antimicrobial investigation on some species of Terminalia and Combretum (Combretaceae) growing in Tanzenia. J. Ethnopharmacol. 79:169-177.
Crossref

  
 

Gansane A, Sanon S, Ouattara LP, Traore A, Hutter S, Ollivier E, Azas N, Traore AS, Guissou IP, Sirima SB (2010). Antiplasmodial activity and toxicity of crude extracts from alternatives parts of plants widely used for the treatment of malaria in Burkina Faso: Contribution for their preservation. Parasitol. Res. 106:335-340.
Crossref

  
 

Grønhaug TE, Glæserud S, Skogsrud M, Ballo N, Bah S, Diallo D, Pualsen BS (2008). Ethnopharmacological survey of six medicinal plants from Mali, West Africa. J. Ethnobiol. Ethnomed. 4:26.
Crossref

  
 

Gruys E, Toussaint MJM, Niewold TA, and Koopmans SJ (2005). Acute phase reaction and acute phase proteins. J. Zhejiang Univ. Sci. B. 6(11):1045-1056.
Crossref

  
 

Karou D, Dicko, MH, Sano S, Simpore J, Traore AS (2003). Antimalarial activity of Sida acuta Burm. F. (Malvaceae) and Pterocarpus erinaceus Poir. (Fabaceae). J. Ethnopharmacol. 89:291-294.
Crossref

  
 

Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, Markiewicz W, Levy Y, Gerald J. Brook, Doron Aronson. (2005). Association between Elevated Liver Enzymes and C-Reactive Protein. Arterioscler. Thromb. Vasc. Biol. 25(1):193-197.

  
 

Ketema T, Yohannes M, Alemayehu E, Ambelu A (2015). Evaluation of immunomodulatory activities of methanolic extract of khat (Catha edulis, Forsk) and cathinone in Swiss albino mice. BMC Immunol. 16:9.
Crossref

  
 

Linthorst GE, Folman CC, van Olden RW, von dem Borne AE (2002). Plasma thrombopoietin levels in patients with chronic renal failure. Hematol. J. 3(1):38-42.
Crossref

  
 

Makar RS, Zhukov OS, Sahud MA, Kuter DJ (2013). Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists. Am. J. Hematol. 88(12):1041-1044.
Crossref

  
 

Masoko P, Picard J, Eloff JN (2007). The antifungal activity of twenty-four Southern African Combretum species (Combretaceae). South Afr. J. Bot. 73:173-183.
Crossref

  
 

McGaw LJ, Rabe T, Sparg SG, Jager AK, Eloff JN, van Staden J (2001). An investigation on the biological activity of Combretum species. J. Ethnopharmacol. 75:45-50.
Crossref

  
 

Miaffo D, Wansi SL, Mbiantcha M, Poualeu SLK, Guessom OK (2015). Toxicological Evaluation of Aqueous and Acetone Extracts of Combretum molle Twigs in Wistar Rats. Electron. J. Biol. 11(2):33-45.

  
 

Mueller M, Hobiger S, Jungbauer A. (2010). Anti-inflammatory activity of extracts from fruits, herbs and spices. Food Chem. 122:987-996.
Crossref

  
 

Ojewole JA (2008). Analgesic and anti-inflammatory effects of mollic acid glucoside, a 1alpha-hydroxycycloartenoid saponin extractive from Combretum molle (Combretaceae) leaf. Phytother. Res. 22:30-35.
Crossref

  
 

Regassa F, Araya M (2012). In vitro antimicrobial activity of Combretum molle (Combretaceae) against Staphylococcus aureus and Streptococcus agalactiae isolated from crossbred dairy cows with clinical mastitis. Trop. Anim. Health Prod. 44:1169-1173.
Crossref

  
 

Sahlu T (2013). Antibacterial activities and preliminary phytochemical investigation of four selected medicinal plants. MSc thesis, Addis Ababa University.

  
 

Sanon S, Gansane A, Ouattara LP, Traore A, Ouedraogo IN, Tiono A, Taramelli D, Basilico N, Sirima SB (2013). In vitro antiplasmodial and cytotoxic properties of some medicinal plants from western Burkina Faso. Afr. J. Lab Med. 2(1):81.
Crossref

  
 

Shah B, Shah N, Seth AK, Maheshwari KM (2011). A review on medicinal plants as a source of anti-inflammatory agents. Res. J. Med. Plants 5:101-115.
Crossref

  
 

Singh A, Bhat TK, Sharma OP (2011). Clinical Biochemistry of Hepatotoxicity. J. Clin. Toxicol. S4:001.

  
 

Thapa BR, Walia A (2007). Liver function tests and their interpretation. Indian J. Pediatr. 74:663-671.
Crossref

  
 

Yeo M, Han SU, Nam KT, Kim DY, Cho SW, Hahm KB (2012). Acute and sub-acute toxic study of aqueous leaf extract of Combretum molle. Trop. J. Pharm. Res. 11:217-223.
Crossref

  
 

Zhang J, Jianxiong AN (2007). Cytokines, Inflammation and Pain. Int. Anesthesiol. Clin. 45(2):27-37.
Crossref

  

 




Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 12 No. 5
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES
          */?>